|
个人信息Personal Information
教授
博士生导师
教师英文名称：Hu-Lin Jiang
教师拼音名称：Jiang Hulin
电子邮箱：
入职时间：2004-09-01
所在单位：药剂系
学历：博士研究生毕业
办公地点：中国药科大学江宁校区学院实验楼1期
性别：男
在职信息：在岗
毕业院校：首尔大学（韩国）
学科：药剂学
- Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer:Nature Communications,2024
- Vicious cycle-breaking lipid nanoparticles remodeling multicellular crosstalk to reverse liver fibrosis:Advanced Materials,2024
- Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling:Journal of Controlled Release,2024
- An autologous macrophage-based phenotypic transformation-collagen degradation system treating advanced liver fibrosis:Advanced Science,2024
- A pro-metastatic derivatives eliminator for in vivo dual-removal of circulating tumor cells and tumor-derived exosomes impedes their biodistribution into distant organs:Advanced Science,2023
- Progress on the pathological tissue microenvironment barrier-modulated nanomedicine:Advanced Drug Delivery Reviews,2023
- Nanoengineered-mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice:Science Advances,2023
- Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy:Biomaterials,2023
- A novel whole blood purifier for efficient capture and separation of circulating tumor cells:Biosensors & Bioelectronics,2023
- Response letter to Sun et al, re: Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy:Journal of Controlled Release,2023
- Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis:Biomaterials,2022
- Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy:Journal of Controlled Release,2022
- Enhanced nuclear gene delivery via integrating and streamlining intracellular pathway:Journal of Controlled Release,2022
- Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy:ACS Nano,2022
- Photothermal nanozyme-ignited Fenton reaction-independent ferroptosis for breast cancer therapy:Journal of Controlled Release,2021